Search results
Showing 1 to 7 of 7 results for bendroflumethiazide
In development [GID-TA11359] Expected publication date: 25 June 2025
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]
In development [GID-TA11454] Expected publication date: 17 December 2025
Targeted-release budesonide for treating primary IgA nephropathy (review of TA937) [ID6485]
In development [GID-TA11662] Expected publication date: 17 December 2025
clinical and cost effectiveness of empirical potassium citrate or bendroflumethiazide as preventive treatment for people with small...
This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.
Renal and ureteric stones: assessment and management (NG118)
This guideline covers assessing and managing renal and ureteric stones. It aims to improve the detection, clearance and prevention of stones, so reducing pain and anxiety, and improving quality of life.
clinical and cost effectiveness of empirical potassium citrate or bendroflumethiazide as preventive treatment for people with small...